Octomera

Octomera is a growing supplier of advanced therapies, offering decentralized autologous GMP manufacturing services supported by an agnostic flexible facility model. Leveraging over a decade of expertise in traditional and next-generation cell and gene therapy engineering through its parent company Orgenesis, the team delivers life-saving treatments to patients at the point of care via proprietary Octomera Processing Units and Labs (OMPULs).